SEPOY.net
No Result
View All Result
Monday, July 14, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Moderna Says Omicron-Specific Booster Should Be Ready by August

Nicholas by Nicholas
June 24, 2022
in Health
0

READ ALSO

EAGLE model predicts key lung cancer mutations from routine biopsy

Is fruit juice good or bad for diabetes? New research reveals a genetic twist

THURSDAY, June 23, 2022 (HealthDay News) – Moderna Inc. announced Wednesday that the revamped COVID booster shot it has developed to fight Omicron and its subvariants should be ready for public use by August.

The company has been making shots of the vaccine, called mRNA-1273.214, before getting regulatory approval so it can be ready to ship doses out for the fall and winter, when health experts worry that there could be another wave of COVID-19.

“In the face of SARS-CoV-2’s continued evolution, we are very encouraged that mRNA-1273.214, our lead booster candidate for the fall, has shown high neutralizing titers against the BA.4 and BA.5 [Omicron] subvariants, which represent an emergent threat to global public health,” Moderna CEO Stephane Bancel said in a company news release.

“We will submit these data to regulators urgently and are preparing to supply our next generation bivalent [targeted to two variants] booster starting in August, ahead of a potential rise in SARS-CoV-2 infections due to Omicron subvariants in the early fall,” Bancel added.

Already, the BA.4 and BA.5 subvariants account for 35% of all reported infections in the United States, up from 23% a week ago, the latest data from the U.S. Centers for Disease Control and Prevention shows.

The vaccine is targets both Omicron and the original strain of the virus, unlike the first vaccine which just targeted the original strain. In the latest data that Moderna released on Wednesday, the updated shot boosted antibodies against the BA.4/BA.5 subvariants by 5.4-fold above baseline in all participants regardless of prior infection, and by 6.3-fold in the subset of participants who had no detectable COVID antibodies in their blood before getting their shot.

“We’d really like to be ready for the fall season later this year,” Lavina Talukdar, head of investor relations at Moderna, said at a Goldman Sachs health care conference last week, CBS News reported. “In the Northern hemisphere, that’s when we think that susceptibility to infections is going to go up higher just because we’ll spend more time indoors.”

The product could be ready to ship “toward the end of August, early September, October-ish time frame,” Talukdar said at the time.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCE: Moderna, news release, June 22, 2022; CBS News

By Cara Murez and Robin Foster HealthDay Reporters

MedicalNews

Copyright © 2021 HealthDay. All rights reserved.

Tags: Moderna Says Omicron Specific Booster Should Be Ready by August

Related Posts

EAGLE model predicts key lung cancer mutations from routine biopsy
Health

EAGLE model predicts key lung cancer mutations from routine biopsy

July 14, 2025
Is fruit juice good or bad for diabetes? New research reveals a genetic twist
Health

Is fruit juice good or bad for diabetes? New research reveals a genetic twist

July 14, 2025
Underactive thyroid linked to increased risk of small intestinal bacterial overgrowth
Health

Underactive thyroid linked to increased risk of small intestinal bacterial overgrowth

July 12, 2025
Adults over 80 benefit from osteoporosis medications
Health

Adults over 80 benefit from osteoporosis medications

July 12, 2025
OneTouch-PAT system detects breast cancer in under a minute without compression
Health

OneTouch-PAT system detects breast cancer in under a minute without compression

July 12, 2025
Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy
Health

Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy

July 12, 2025
Next Post

What are the advantages of learning Java?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Casino inte me konto Din denna sajt ultimat svenska språket guide 2023
  • Ancient Program Position Opinion & Casinos: Rigged otherwise Secure to help you Spin?
  • Hitta fler Casinon med Free casino Superlenny recension Spins

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net